BNET Industries

Advanced Viral Research Corp.

(ADVR) is in the Pharma Industry

Market Cap:$1.7M
Last Fiscal Year Sales:$250.4K
  • Public
  • US
Dow Jones Description

Advanced Viral Research Corp. was incorporated in Delaware in July 1985 to engage in the production and marketing, promotion and sale of a pharmaceutical drug known by the trademark Reticulose®. This drug was the forerunner of our current drug, ?AVR118.? AVR118 is biopolymer that possesses immunomodulatory activity. It is a peptide-nucleic acid complex, and we believe it may be employed in the treatment of diseases and conditions such as: ? Cachexia, or body wasting, in patients with acquired immune deficiency syndrome (AIDS), and cancer; ? Various conditions associated with cancer; ? Human immunodeficiency virus, or HIV, including AIDS as a combination therapy; ? Human papilloma virus, or HPV; and ? Rheumatoid arthritis.

President and Chief Executive Officer, Director
Stephen M Elliston
Number of Employees 14
Contact Information

200 Corporate Boulevard South

.

Yonkers, New York 10107

adviral.com

9143767383

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

News & Analysis

advanced viral research corp. - All News and Analysis

Decision Makers

Name (plus bio) Position
Stephen M Elliston President and Chief Executive Officer, Director
Martin Bookman Acting Chief Financial Officer, Secretary
Vincent P Gullo Chief Scientific Officer
Dallas E Hughes Vice President, Research
Maribel De Diego Director, Product Development
Yuriy Dunayevskiy Research Fellow
Nancy Van Sant Director

Board of Directors

Name (plus bio) Position
Eli Wilner Chairman
Angelo S Botter Board of Directors
Roy Walzer Board of Directors

Organization Position Status
Advanced Viral Research Corp President and Chief Executive Officer, Director Current
Eli Wilner & Company CEO Current
Eli Wilner & Company Founder Current
Advanced Viral Research Corp Board of Directors Current
Burroughs Wellcome Co. - USA Former
Schering-Plough Corporation Former

Martin Bookman has been Acting CFO since April 2004. Mr. Bookman was our assistant controller from March 2001 to April 2004. From August 2000 to March 2001 Mr. Bookman was a senior consultant for Prodigy Communications, Inc. From August 1997 to August 2000 Mr. Bookman was manager of policies and procedures and assistant controller for Murray Feiss Import Corp.

Organization Position Status
Advanced Viral Research Corp Acting Chief Financial Officer, Secretary Current
Murray Feiss Import Corp Manager Former
Murray Feiss Import Corp Assistant Controller Former
Prodigy Communications Senior Consultant Former

Organization Position Status
Advanced Viral Research Corp Chief Scientific Officer Current

Organization Position Status
Advanced Viral Research Corp Vice President, Research Current

Organization Position Status
Advanced Viral Research Corp Director, Product Development Current
Advanced Viral Research Corp Senior Research Scientist Former

Organization Position Status
Advanced Viral Research Corp Research Fellow Current

Eli Wilner, age 50, joined the Board of Directors in December 2001, was elected Chairman of the Board in May 2002. Mr. Wilner brings strong entrepreneurial and business management experience to the Company. He is Founder and Chief Executive Officer of Eli Wilner & Company, a New York City-based art gallery and one of the world's largest resource for antique American and European frames. Mr. Wilner currently holds a greater than 1% ownership interest in the following technology and biopharmaceutical companies: Biofem, Chronix, ION, Pararllel Communications. He was a member of the Board of Touchpoint Software Company from 1999-2001, and during his tenure approximately 50% of Touchpoint was acquired by WebMD. A published authority in the art world, Mr. Wilner has brought his expertise to the White House and as a member of various art societies around the nation.

Organization Position Status
Eli Wilner & Company Chief Executive Officer Current
Eli Wilner & Company Founder Current
Advanced Viral Research Corp Chairman Current
Galleryplayer, Inc Board of Directors Current
The Metropolitan Museum of Art Board of Directors Current
The Metropolitan Museum of Art Member Current
Eli Wilner & Company Owner Former
Hunter College of the City University of New York Former
Brandeis University Former

Organization Position Status
Advanced Viral Research Corp Board of Directors Current

Organization Position Status
Advanced Viral Research Corp Director Current
Waldman & Company Director Former

Organization Position Status
Litchfield Partners President Current
Litchfield Partners Founder Current
Advanced Viral Research Corp Board of Directors Current
advertisement
     ADVR $0.00 -0.00 (-4.55% )
Intraday | 3 Month | 6 Month | 1 Year
Average Volume 998,143
Shares Outstanding 880.71M
Market Cap 1.8M
Year High 0.006
Year Low 0.0005
Earnings Per Share N/A
P/E Ratio -
Dividend N/A
Yield N/A
IndustryTop Rated
advertisement
Click Here